Core Insights - Huron has acquired the payor consulting services division of AXIOM Systems, enhancing its capabilities in the payor ecosystem [1] Company Summary - The acquisition allows Huron to expand its service offerings in healthcare information technology, particularly in core administration systems and digital transformation for payors and payor-provider organizations [1] - Mark Hussey, the chief executive, expressed enthusiasm about integrating AXIOM's consulting services team into Huron [1]

Core Insights - Ronald Dail, Chief Operating Officer of Huron Consulting Group, sold 7,991 shares for approximately $1.4 million, representing about 20.5% of his direct holdings at the time of the transaction [1][3][10] Transaction Summary - The transaction involved the sale of 7,991 shares valued at ~$1.4 million, with post-transaction holdings of 31,017 shares worth ~$5.1 million [2] - The sale was executed at a weighted average price of $169.56 per share, while the stock closed at $164.44 on October 31 [5] Historical Context - This sale is the largest executed by Dail in the past year, significantly exceeding previous sales of 1,421 shares and 600 shares [4] - Cumulatively, Dail's net sales in 2025 have reduced his direct holdings by 24.4% since February [6] Company Overview - Huron Consulting Group employs 6,405 individuals and reported a revenue of $1.6 billion with a net income of $108.4 million [7] - The company experienced a 42.1% price change over the past year, indicating strong market performance [7] Business Strategy - Huron Consulting Group focuses on high-value consulting across healthcare, education, and business advisory sectors, emphasizing technology-enabled solutions and deep industry expertise [8][9] - The company generates revenue through advisory and managed services aimed at enhancing operational efficiency and digital enablement [9] Recent Performance - Following the third-quarter earnings release, Huron's revenue before reimbursable expenses increased by 16.8% year-over-year to $432.4 million, with earnings per share growing over 16% to $0.24 [11] - Management projects revenue for the year to be between $1.65 billion and $1.67 billion, reflecting an annual growth rate of 11.4% at the midpoint [12]

Huron Consulting (HURN) came out with quarterly earnings of $2.1 per share, beating the Zacks Consensus Estimate of $1.86 per share. This compares to earnings of $1.68 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +12.90%. A quarter ago, it was expected that this consulting company would post earnings of $1.79 per share when it actually produced earnings of $1.89, delivering a surprise of +5.59%.Over the last four quarters, ...

Financial Data and Key Metrics Changes - Company-wide revenues before reimbursable expenses (RVR) grew 17% in Q3 2025, including 10% organic growth, reflecting strong demand and execution [3][20] - RVR for Q3 2025 was a record $432.4 million, up 16.8% from $370 million in Q3 2024 [19] - Net income for Q3 2025 was $30.4 million or $1.71 per diluted share, compared to $27.1 million or $1.47 per diluted share in Q3 2024 [21] - Adjusted EBITDA was $67.4 million in Q3 2025, or 15.6% of RVR, compared to $54.9 million or 14.8% of RVR in Q3 2024 [22] - Adjusted net income was $37.4 million or $2.10 per diluted share in Q3 2025, a 25% increase over Q3 2024 [23] Business Line Data and Key Metrics Changes - Healthcare segment RVR grew 20% year-over-year, with organic growth of 19% excluding recent acquisitions [4][24] - Education segment RVR grew 7% year-over-year, driven by strong demand for strategy and operations, research, and digital offerings [9][10] - Commercial segment RVR grew 27% year-over-year, driven by acquisitions and continued organic growth [12][25] Market Data and Key Metrics Changes - The healthcare segment generated 51% of total company RVR in Q3 2025, with a record RVR of $219.5 million [23] - The education segment accounted for 30% of total company RVR, with a record RVR of $129.4 million [25] - The commercial segment generated 19% of total company RVR, with a record RVR of $83.4 million [26] Company Strategy and Development Direction - The company aims to leverage AI and automation across its offerings to drive value creation and efficiency [8][16] - The strategy includes integrating commercial offerings to enhance the go-to-market strategy and drive above-average growth [15][16] - The company is focused on delivering demonstrable ROI for clients, which is critical for maintaining strong client relationships and repeat business [34] Management's Comments on Operating Environment and Future Outlook - Management noted strong demand across core end markets, positioning the company well for continued growth in 2026 [4][17] - The company expects to achieve full-year 2025 RVR guidance of $1.65 billion-$1.67 billion and adjusted non-GAAP EPS of $7.50-$7.70 [16][30] - Management highlighted the importance of a strong culture in attracting and retaining talent, which supports growth [49][50] Other Important Information - The company closed on acquisitions of Treliant and Wilson Perumal, contributing to growth in the commercial segment [19][14] - The effective income tax rate for Q3 2025 was 28.7%, with an expected full-year rate of 23%-25% [22] - The company repurchased approximately 147,000 shares in Q3 2025, totaling $152.5 million year-to-date [30] Q&A Session Summary Question: Insights on performance improvement in healthcare - Management noted strong market conditions driven by margin pressures, leading to increased demand for performance improvement services [33][34] Question: Outlook for 2026 - Management indicated confidence in the multi-year growth model discussed at the investor day, with potential for higher outcomes based on continued execution [40][41] Question: Demand inflection in commercial segment - Management observed improved sales conversion in financial advisory and strategy offerings, indicating a positive trajectory [44][45] Question: Hiring capabilities for growth - Management expressed confidence in hiring capabilities, supported by a strong culture that attracts talent and reduces attrition [49][50] Question: Customer decision-making in education - Management noted a stable outlook in education, with clients making long-term decisions amidst previous disruptions [51][52] Question: Utilization rates and margin expansion - Management acknowledged lower utilization due to headcount additions but expects improvement as projects ramp up [74][76] Question: AI focus in projects - Management indicated that approximately 15%-20% of total revenue is related to AI projects, with expectations for growth in this area [64][66]

Financial Data and Key Metrics Changes - Company-wide revenues before reimbursable expenses (RVR) grew 17% in Q3 2025, including 10% organic growth, reflecting strong demand and execution [3][20] - RVR for Q3 2025 was a record $432.4 million, up 16.8% from $370 million in Q3 2024 [19] - Net income for Q3 2025 was $30.4 million or $1.71 per diluted share, compared to $27.1 million or $1.47 per diluted share in Q3 2024 [21] - Adjusted EBITDA was $67.4 million in Q3 2025, or 15.6% of RVR, compared to $54.9 million or 14.8% of RVR in Q3 2024 [22] Business Line Data and Key Metrics Changes - Healthcare segment RVR grew 20% year-over-year, achieving a record $219.5 million in Q3 2025 [4][24] - Education segment RVR grew 7% year-over-year, reaching $129.4 million in Q3 2025 [9][25] - Commercial segment RVR grew 27% year-over-year, achieving $83.4 million in Q3 2025 [12][26] Market Data and Key Metrics Changes - The healthcare segment generated 51% of total company RVR in Q3 2025, with an organic growth rate of 18.6% [23][24] - The education segment accounted for 30% of total company RVR, with a 25.7% operating income margin [25] - The commercial segment generated 19% of total company RVR, with a decline in operating income margin to 16.4% [26] Company Strategy and Development Direction - The company aims to leverage AI and automation across its offerings to drive value creation and efficiency [8][12] - The strategy includes integrating commercial offerings to enhance the go-to-market strategy and drive above-average growth [15][16] - The company is focused on delivering demonstrable ROI for clients, which is critical for maintaining competitive advantage [34] Management's Comments on Operating Environment and Future Outlook - Management noted strong demand across core end markets, positioning the company well for continued growth in 2026 [4][17] - The company expects to achieve full-year 2025 RVR guidance of $1.65 billion to $1.67 billion, affirming adjusted EBITDA guidance [16][30] - Management highlighted the importance of a strong culture in attracting and retaining talent, which supports growth [49][50] Other Important Information - The company closed on acquisitions of Treliant and Wilson Perumal & Company, contributing to growth in the commercial segment [19][14] - The effective income tax rate for Q3 2025 was 28.7%, with an expected full-year rate of 23% to 25% [22] Q&A Session Summary Question: Insights on performance improvement in healthcare - Management noted strong market conditions driven by margin pressures, leading to increased demand for performance improvement services [33][34] Question: Outlook for 2026 - Management indicated confidence in the multi-year growth model discussed at the investor day, with continued execution expected to drive growth [41] Question: Demand in commercial segment - Management observed an inflection point in demand for strategy and financial advisory services, contributing to improved sales conversion [44][45] Question: Hiring capabilities - Management expressed confidence in hiring capabilities, attributing low attrition rates to a strong company culture [49][50] Question: AI focus in projects - Approximately 15% to 20% of total revenue is related to AI projects, with expectations for this to grow as AI becomes integrated into more offerings [64][66]

Financial Data and Key Metrics Changes - Company-wide revenues before reimbursable expenses (RVR) grew 17% in Q3 2025, including 10% organic growth, reflecting strong demand and execution [3][19] - RVR for Q3 2025 was a record $432.4 million, up 16.8% from $370 million in Q3 2024 [19] - Net income for Q3 2025 was $30.4 million or $1.71 per diluted share, compared to $27.1 million or $1.47 per diluted share in Q3 2024 [20] - Adjusted EBITDA was $67.4 million in Q3 2025, or 15.6% of RVR, compared to $54.9 million or 14.8% of RVR in Q3 2024 [21] Business Line Data and Key Metrics Changes - Healthcare segment RVR grew 20% year-over-year, achieving a record $219.5 million in Q3 2025 [4][23] - Education segment RVR grew 7% year-over-year, reaching $129.4 million in Q3 2025 [9][25] - Commercial segment RVR grew 27% year-over-year, reaching $83.4 million in Q3 2025 [12][26] Market Data and Key Metrics Changes - The healthcare segment generated 51% of total company RVR in Q3 2025, with an organic growth rate of 18.6% [23][24] - The education segment accounted for 30% of total company RVR, with strong demand for strategy and operations, research, and digital offerings [10][25] - The commercial segment generated 19% of total company RVR, with growth driven by acquisitions and organic growth in digital business [12][26] Company Strategy and Development Direction - The company aims to leverage AI and automation across its offerings to drive value creation and efficiency [7][8] - Continued focus on integrating commercial offerings to enhance go-to-market strategy and drive above-average growth [15][16] - The company expects to achieve full-year 2025 RVR guidance of $1.65 billion to $1.67 billion, affirming adjusted EBITDA guidance of 14% to 14.5% of RVR [17][31] Management's Comments on Operating Environment and Future Outlook - Management noted strong demand across core end markets, positioning the company well for continued growth in 2026 [4][17] - The healthcare segment is experiencing persistent margin pressures, leading clients to seek comprehensive solutions [6][36] - Management expressed confidence in the ability to sustain accelerated RVR growth and margin expansion despite macroeconomic challenges [17][30] Other Important Information - The company completed several acquisitions, including Eclipse Insights, Treliant, and Wilson Perumal & Company, which contributed to revenue growth [19][12] - The effective income tax rate for Q3 2025 was 28.7%, with expectations for a full-year rate of 23% to 25% [21][30] - Free cash flow for Q3 2025 was $85.3 million, with full-year expectations in the range of $165 million to $185 million [28][30] Q&A Session Summary Question: Insights on performance improvement in healthcare - Management highlighted strong market demand driven by margin pressures and the need for transformation, with a record pipeline and larger project scopes [33][34][39] Question: Outlook for 2026 - Management indicated confidence in continued demand and execution, aligning with previously discussed multi-year targets [42][43] Question: Demand in commercial segment - Management noted an inflection point in demand for strategy and financial advisory services, with improved sales conversion [44][45] Question: Hiring capabilities - Management expressed confidence in hiring capabilities, citing a strong culture that attracts talent and leads to lower attrition rates [47][48] Question: Customer decision-making in education - Management observed a stable outlook in education, with clients making long-term decisions amidst previous disruptions [49] Question: Utilization rates and project absorption - Management confirmed high utilization rates in managed services, with a tight correlation between sales and hiring [50][51] Question: AI focus in projects - Management reported that approximately 15% to 20% of total revenue is related to AI projects, with expectations for growth in this area [60][61]

Growth and Acquisitions - Huron Consulting Group reported strong growth in healthcare and education sectors, aiming to broaden its portfolio to meet evolving market needs[163]. - The company has enhanced its consulting offerings through acquisitions, including Eclipse Insights for revenue cycle solutions in June 2025[166]. - Huron's education segment has been bolstered by acquisitions such as Grenzebach Glier and Associates in March 2024, enhancing its global philanthropy consulting services[167]. - The commercial segment has seen growth through acquisitions like AXIA Consulting in December 2024, expanding its supply chain management offerings[168]. - The acquisition of Treliant added approximately 180 revenue-generating professionals to the Commercial segment in Q3 2025[213]. - Incremental revenues before reimbursable expenses from acquisitions since Q3 2024 amounted to $28.3 million[201]. Financial Performance - Revenues before reimbursable expenses increased by $62.3 million, or 16.8%, to $432.4 million for Q3 2025 from $370.0 million for Q3 2024[201]. - Total revenues for the company reached $441.3 million in Q3 2025, compared to $378.1 million in Q3 2024, representing a 16.7% increase[210]. - Net income increased by $3.3 million, or 12.0%, to $30.4 million for Q3 2025 from $27.1 million in Q3 2024, with diluted earnings per share rising to $1.71 from $1.47[234]. - Adjusted EBITDA increased by $12.6 million, or 22.9%, to $67.4 million, or 15.6% of revenues before reimbursable expenses for Q3 2025 compared to 14.8% for Q3 2024[207]. - Adjusted net income increased by $6.3 million, or 20.3%, to $37.4 million in Q3 2025, with adjusted diluted earnings per share increasing to $2.10 from $1.68[238]. Segment Performance - Healthcare segment revenues before reimbursable expenses increased to $219.5 million in Q3 2025 from $183.1 million in Q3 2024, a growth of 19.9%[210]. - Education segment revenues before reimbursable expenses rose to $129.4 million in Q3 2025, compared to $121.0 million in Q3 2024, reflecting a 6.9% increase[210]. - Commercial segment revenues before reimbursable expenses grew to $83.4 million in Q3 2025, up from $65.9 million in Q3 2024, marking a 26.5% increase[210]. - Healthcare operating income increased by $18.1 million, or 36.5%, with an operating margin of 30.9%[227]. - Education operating income rose by $4.1 million, or 14.0%, with an operating margin of 25.7%[227]. - Commercial operating income decreased by $2.5 million, or 15.4%, with an operating margin of 16.4%[228]. Operational Efficiency - Huron's operational efficiency initiatives aim for margin expansion and strong annual adjusted diluted earnings per share growth[164]. - The utilization rate within the Consulting capability increased to 73.7% in Q3 2025, compared to 73.6% in Q3 2024[202]. - The total number of revenue-generating professionals increased by 15.2% to 5,244 as of September 30, 2025, compared to 4,551 as of September 30, 2024[204]. - The number of Managed Services professionals increased by 55.5% to 2,091 as of September 30, 2025, from 1,345 as of September 30, 2024[204]. Cash Flow and Capital Management - The company maintains a strong balance sheet and cash flow, committed to strategic capital deployment and shareholder returns[164]. - Returned $152.5 million to shareholders in the first nine months of 2025 by repurchasing 1,084,794 shares of common stock[208]. - Cash and cash equivalents increased to $23.9 million as of September 30, 2025, compared to $21.9 million at the end of 2024[263]. - Net cash provided by operating activities increased by $5.3 million to $67.0 million for the nine months ended September 30, 2025, from $61.7 million in 2024[267]. - Net cash used in investing activities for the nine months ended September 30, 2025, was $133.2 million, primarily for business purchases ($107.2 million) and software development ($15.4 million)[270]. Risks and Challenges - The company faces risks related to client retention, market volatility, and integration of acquired businesses, which could impact future performance[161]. - The company has exposure to interest rate risks, with a hypothetical 100 basis point change in interest rates potentially affecting pretax income by $3.6 million annually[297]. - The company does not use derivative instruments for trading or speculative purposes, minimizing market risk exposure[306]. Investments and Impairments - The fair value of the investment in Shorelight Holdings, LLC decreased to $32.8 million as of September 30, 2025, from $62.3 million at December 31, 2024, reflecting a non-cash credit-related impairment charge of $11.1 million[303]. - The equity investment in the hospital-at-home company had a carrying value of $2.4 million as of September 30, 2025, down from $7.4 million at December 31, 2024, after recognizing a total non-cash impairment charge of $5.0 million[304]. - The total cost basis of the investment in Shorelight Holdings, LLC is $40.9 million, indicating a fair value decline of approximately 47.3% over the nine months of 2025[303].

Financial Performance - Revenues before reimbursable expenses increased $62.3 million, or 16.8%, to a record $432.4 million in Q3 2025 from $370.0 million in Q3 2024[3] - Net income increased $3.3 million, or 12.0%, to $30.4 million in Q3 2025, compared to $27.1 million in Q3 2024[3] - Adjusted EBITDA increased $12.6 million, or 22.9%, to $67.4 million in Q3 2025 from $54.9 million in Q3 2024[3] - Diluted earnings per share increased $0.24, or 16.3%, to $1.71 in Q3 2025, compared to $1.47 in Q3 2024[3] - Revenues before reimbursable expenses increased $132.9 million, or 12.1%, to $1.23 billion for the first nine months of 2025 from $1.10 billion for the same prior year period[12] - Adjusted diluted earnings per share increased $1.10, or 24.1%, to $5.67 for the first nine months of 2025 from $4.57 for the same prior year period[15] - Total revenues for the nine months ended September 30, 2025, reached $1,257,180,000, compared to $1,122,491,000 for the same period in 2024, reflecting a 12.0% growth[24] - Net income for the nine months ended September 30, 2025, was $74.386 million, a decrease of 10.2% from $82.637 million in 2024[28] - Adjusted net income for the first nine months of 2025 was $102.1 million, a 19.8% increase from $85.3 million in the same period of 2024[36] Shareholder Returns - Huron returned $152.5 million to shareholders by repurchasing 1.1 million shares of common stock for the first nine months of 2025[12] - The company repurchased shares amounting to $153.097 million during the nine months ended September 30, 2025[28] Operational Metrics - The number of revenue-generating professionals increased 15.2% to 5,244 as of September 30, 2025, from 4,551 as of September 30, 2024[11] - Total assets as of September 30, 2025, were $1,544,182,000, an increase from $1,343,617,000 at the end of 2024, indicating a growth of 14.9%[26] - Current liabilities decreased to $330,054,000 from $338,820,000, a reduction of 2.1%[26] - Long-term debt increased to $589,591,000 as of September 30, 2025, compared to $342,857,000 at the end of 2024, reflecting a significant rise of 72.2%[26] - The company anticipates adjusted EBITDA as a percentage of revenues before reimbursable expenses in a range of 14.0% to 14.5% for 2025[17] - The company anticipates continued growth in adjusted EBITDA as a percentage of revenues, although specific guidance for reconciling items was not provided[20] Segment Performance - Healthcare segment revenues before reimbursable expenses for the three months ended September 30, 2025, rose by 19.9% to $219.541 million compared to $183.136 million in 2024[30] - Operating income for the Healthcare segment for the nine months ended September 30, 2025, increased by 24.5% to $183.724 million from $147.591 million in 2024[30] - The number of revenue-generating professionals in the Healthcare segment increased by 17.1% to 1,428 as of September 30, 2025, from 1,219 in 2024[30] - Managed Services capability revenues before reimbursable expenses in the Healthcare segment for the nine months ended September 30, 2025, were $64.3 million, up from $53.5 million in 2024[32] - The Commercial segment's revenues before reimbursable expenses for the three months ended September 30, 2025, increased by 26.6% to $83.396 million compared to $65.865 million in 2024[30] Cash Flow and Liquidity - Total cash provided by operating activities for the nine months ended September 30, 2025, was $66.987 million, an increase from $61.704 million in 2024[28] - Cash and cash equivalents at the end of the period increased to $23.889 million from $18.497 million in 2024[28] Management Insights - Management emphasizes the importance of non-GAAP measures for understanding operational performance and future prospects[19] - The company is focused on optimizing operations and accelerating digital transformation to enhance client services and drive sustainable results[21] Other Financial Information - The company incurred $3.5 million in restructuring charges in Q3 2025, slightly up from $3.1 million in Q3 2024[36] - Unrealized losses on long-term investments amounted to $16.1 million for the first nine months of 2025, impacting the financial results[37] - The company reported a net income as a percentage of total revenues of 6.9% in Q3 2025, down from 7.2% in Q3 2024[34]

The conference call is being webcast by Notified and can be accessed on Huron's website at http://ir.huronconsultinggroup.com. A replay will be available approximately two hours after the conclusion of the webcast and for 90 days thereafter. Oct 14, 2025 9:05 AM Eastern Daylight Time CHICAGO--(BUSINESS WIRE)--Global professional services firm Huron (NASDAQ: HURN) will announce its financial results for the third quarter ended September 30, 2025, after the market closes on Tuesday, October 28, 2025. ABOUT HU ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...